Back to Search
WILLIAM TILLEY, MD
MD
Cardiovascular Disease Physician
NPI: 1730185380Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
29177(NC)
Research & Publications (20)
Serum testosterone bioassay evaluation in a large male cohort.
PMID 19508600·Clin Endocrinol (Oxf)·2010
4-observational
Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition.
PMID 18509757·Breast Cancer Res Treat·2009
8-other
The dynamic and static modification of the epigenome by hormones: a role in the developmental origin of hormone related cancers.
PMID 19166905·Biochim Biophys Acta·2009
6-review
Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome.
PMID 19189303·Prostate·2009
4-observational
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
PMID 19638585·Cancer Res·2009
7-preclinical
Testosterone therapy in castrate-resistant prostate cancer: a possible new approach.
PMID 19409691·Eur Urol·2009
8-other
A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin.
PMID 19282387·Endocrinology·2009
7-preclinical
Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse.
PMID 18768520·Cancer Epidemiol Biomarkers Prev·2008
8-other
Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.
PMID 18324648·Prostate·2008
8-other
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
PMID 18515094·J Steroid Biochem Mol Biol·2008
8-other
The contribution of different androgen receptor domains to receptor dimerization and signaling.
PMID 18617596·Mol Endocrinol·2008
6-review
The 3rd Pacific Rim meeting on breast and prostate cancer: progress in hormonal carcinogenesis and the enduring influence of Ron Ross.
PMID 17510379·Cancer Res·2007
7-preclinical
Identification of novel androgen receptor target genes in prostate cancer.
PMID 17553165·Mol Cancer·2007
4-observational
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
PMID 17416768·Cancer Epidemiol Biomarkers Prev·2007
8-other
Role of oncoprotein growth factor independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): a comparative analysis in human prostate cancer and kidney cells.
PMID 17207994·J Steroid Biochem Mol Biol·2007
4-observational
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.
PMID 17218635·Mol Cancer Ther·2007
8-other
Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.
PMID 17293599·J Biol Chem·2007
4-observational
Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptor.
PMID 17336451·Mol Cell Endocrinol·2007
8-other
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.
PMID 17413000·FASEB J·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1002 N CHURCH ST, STE 202
GREENSBORO, NC 27401 - Phone
- (336) 274-7581
Quick Facts
- NPI
- 1730185380
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile